Evolva acquires Allylix for $61 million, acquisition trend continues
November 27, 2014 | Analyst Insight
This week, Evolva acquired Allylix, which will now become a wholly owned subsidiary of Evolva. Evolva will acquire Allylix in exchange for 46 million Evolva shares, valued at $61...
Intermediate chemical products
About Lux Research
Lux Research is a leading provider of tech-enabled research and advisory solutions, helping clients drive growth through technology innovation. A pioneer in the research industry, Lux uniquely combines technical expertise and business insights with a proprietary intelligence platform, using advanced analytics and data science to surface true leading indicators. With quality data derived from primary research, fact-based analysis, and opinions that challenge traditional thinking, Lux clients are empowered to make more informed decisions today to ensure future success.